Tg Therapeutics Inc (TGTX)

R&D Expense Growth

96.99%

Quarterly · Period ending:

TGTX logo

TGTX R&D Expense Growth

Latest reported96.99%
TGTX Quarterly R&D Growth (QoQ) (0.00% → 96.99%)
High-resolution chart · PNG

TGTX r&d expense growth history

Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.

Tg Therapeutics Inc R&D Expense Growth — Quarterly
Period endingR&D Expense Growth
96.9936%
17.486%
0.7706%
28.62%
-31.4482%
94.1945%
18.552%
14.7072%
-46.348%
87.5294%
18.2742%
-34.3085%
41.5123%
-46.4485%
42.4691%
-22.5981%
-44.0614%
-23.3119%
20.5496%
15.8142%
-28.8823%
46.8634%
-14.868%
38.451%
1.1854%
22.2992%
-47.8718%
79.2949%
2.0003%
-39.5015%
55.9168%
-13.3767%
17.5783%
24.9568%
1.5841%
-0.4116%
24.8515%
-4.8515%
2.5702%
61.0148%
15.4594%
-18.181%
18.9602%
16.5219%
19.6002%
-35.3548%
2.5339%
252.0554%
41.4536%
-30.4495%
14.9219%
-32.6794%
283.5951%
41.2661%
-44.8859%
-5.1815%
-90.1675%
7,922.7332%
-323.1655%
6.2948%
-74.5991%
86.6474%
-19.6174%
364.1934%
187.0434%
205.8946%
-401.0047%
-16.1048%
-85.2145%
172.6414%
-112.4004%
-11.8211%
-29.2903%
-31.9463%
-35.0097%
-53.2766%
130.5302%
-12.7421%
88.0601%
-29.6025%
-28.1472%
-85.3105%
904.8548%
43.1971%
-0.7059%
-22.6181%
-25.7971%
223.5193%
-26.832%
-28.334%
161.948%
20.6414%
622.3527%
-40.2815%
-42.095%
-10.4041%
-30.671%
79.6131%
-34.7626%
0%
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.